NCT03167918View on ClinicalTrials.gov

Lung Function in Patients With Early Type 2 Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 21, 2014

Primary Completion Date

April 1, 2017

Study Completion Date

May 1, 2017

Conditions
Type 2 Diabetes MellitusPulmonary Function
Interventions
DRUG

Calcium Dobesilate

gave each patient 0.5 g bid，

DRUG

Xuefuzhuyu Decoction

gave each patient100 ml bid，po

DRUG

Xuefuzhuyu Decoction & Calcium dobesilate

gave each patient Calcium dobesilate 0.5 g bid，po and Xuefuzhuyu Decoction 100 ml bid，po

DRUG

metformin

gave each patient 1000 mg, bid, PO

DRUG

Mecobalamin Tablets

gave each patient 0.5 mg bid, PO

All Listed Sponsors
lead

Liaoning University of Traditional Chinese Medicine

OTHER

NCT03167918 - Lung Function in Patients With Early Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter